NCT05146245View on ClinicalTrials.gov

Safety and Pharmacokinetics of Antipsychotics in Children 2: Studying TDM in an RCT

PHASE4RecruitingINTERVENTIONAL
Enrollment

140

Participants

Timeline

Start Date

December 1, 2021

Primary Completion Date

May 31, 2024

Study Completion Date

May 31, 2024

Conditions
Autism Spectrum Disorder
Interventions
OTHER

Therapeutic Drug Monitoring

Physician receives dosing advice based on risperidone plasma level.

OTHER

Risperidone plasma level

Plasma levels of risperidone and 9-OH risperidone are measured in a Dried Blood Spot.

Trial Locations (1)

Unknown

RECRUITING

Erasmus Medical Center, Rotterdam

Sponsors
All Listed Sponsors
collaborator

Stichting de Merel

UNKNOWN

collaborator

ZonMw: The Netherlands Organisation for Health Research and Development

OTHER

lead

Erasmus Medical Center

OTHER